Zenlabs Ethica
ZENLABSBSE

Zenlabs Ethica

₹35.50-1.02 (2.79%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
35.50
Today’s high
35.50
52 week low
16.50
52 week high
39.99
Open price
35.50
Previous close
36.52
Live volume
3
Lower circuit
34.70
Upper circuit
38.34

Fundamentals

Market Cap
₹24Cr
ROE
0.23%
P/E Ratio(TTM)
--
EPS(TTM)
-2.97
P/B Ratio
2.79
Dividend Yield
0.00%
Industry P/E
44.59
Book Value
13.07
Debt to Equity
1.29
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
MAR '26
Revenue (Cr)
₹10.70
-13.92%
Profit (Cr)
₹0.00
+100.00%
-5051015
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Revenue growthValue
1Y (TTM)-18%
3Y CAGR-9%
Profit growthValue
3Y CAGR-30%

About

Zenlabs Ethica Limited is a top Indian marketing company that trades a wide variety of branded drugs for treatments like GIT disorders, anti-diabetics, and anti-infectives. The company's core mission is to improve the quality of life for people by providing high-quality, affordable, and branded pharmaceutical products. Its corporate sustainability policy is demonstrated through fair governance, community engagement, and respect for human rights. In recent years, the company has refined its business models, reshaped its product portfolio, and expanded its geographical footprint to boost its competitive standing. Building on its success, it has strategically ventured into diverse new segments such as Neurology and Cytrics. Zenlabs Ethica is considered one of the top 10 pharmaceutical contract manufacturing companies in India.;
CEO/MD
Mr. Sanjeev Kumar
Founded in
1993
BSE symbol
530697

Shareholding Pattern

Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Promoters
52.96%
Retail And Others
47.04%
2026
29
May
Annual Result
Release date
7
Feb
Quarterly Result
Release date
2025
8
Nov
Quarterly Result
Release date
8
Aug
Quarterly Result
Release date
Events calendar
View upcoming events in other stocks